Hangover headaches are a common problem over the holidays, but there are ways to prevent them, an expert says. The best way to avoid a hangover headache is to stick to non-alcoholic drinks such as sodas, spritzers and punches, said Dr. ...
Many children with attention-deficit hyperactivity disorder (ADHD) may have missed out on valuable counseling because of a widely touted study that concluded stimulants such as Ritalin or Adderall were more effective for treating the ...
Tags: attention-deficit hyperactivity disorder, stimulants, medications
In the largest ever assessment of substance use among people with severe psychiatric illness, researchers at Washington University School of Medicine in St. Louis and the University of Southern California have found that rates of smoking, ...
Tags: psychiatric illness, psychotic disorders, rates of smoking
Electromed, Inc. (NYSE MKT: ELMD), a global medical device company, today announced it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest® Airway Clearance System, the model ...
Doctors may need to treat high blood pressure in women earlier and more aggressively than they do in men, according to scientists at Wake Forest Baptist Medical Center. In a new study, published in the December edition of Therapeutic ...
Tags: high blood pressure, women health, treatment
Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels:UCB) today announced results from a Phase 2 trial evaluating romosozumab (AMG 785/CDP7851) in postmenopausal women with low bone mineral density (BMD). Published in the New England Journal of ...
Tags: Amgen, UCB, Phase 2 trial evaluating romosozumab, postmenopausal women
Reportbuyer.com just published a new market research report: China Healthcare Industry IT Solution 2013-2017 Forecast and Analysis This IDC study analyzes the current and future development trends in the IT market in China's healthcare ...
Most large, clinical trials of vitamin supplements, including some that have concluded they are of no value or even harmful, have a flawed methodology that renders them largely useless in determining the real value of these micronutrients, ...
Tags: vitamin supplements, flawed methodology, micronutrients
By Kirsty Oswald, medwireNews Reporter Results from a German national health survey indicate that asthma patients with multiple comorbidities are at increased risk for unplanned hospital admissions. The findings also confirm that ...
Tags: asthma patients, comorbidities, cardiovascular disease, health
Horse owners, in the everyday care of their animals, routinely need to administer medications in one form or another. The most common range from liniments and leg braces, to diverse anthelmintics for controlling internal parasites, to ...
Tags: Equine Medications, Horse
Restricting calorie consumption is one of the few proven ways to combat aging. Though the underlying mechanism is unknown, calorie restriction has been shown to prolong lifespan in yeast, worms, flies, monkeys, and, in some studies, humans. ...
Tags: calorie consumption, aging, calorie restriction, Keren Yizhak, anti-aging
Netherlands-based Micreos has received generally recognized as safe (GRAS) food processing aid against Salmonella status for its SALMONELEX from the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA). ...
Tags: Micreos, Salmonelex
Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) ...
Tags: Can-Fite BioPharma, OphthaliX, placebo-controlled phase III study
Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its supplemental Biologics License Application seeking approval of ...
Tags: Genzyme, Biologics License Application, Lemtrada, multiple sclerosis
Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Envarsus® (formerly ...
Tags: Veloxis Pharmaceuticals, New Drug Application, Envarsus®